VNDA Vanda Pharmaceuticals Inc

Conference Call and Webcast to Follow ROCKVILLE, Md., Aug. 6 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ:VNDA), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced it will release results for the quarter ended June 30, 2009, on Monday, August 10, 2009, before the market opens. A full text copy of the release will be disseminated at that time. Mihael H. Polymeropoulos, M.D., President and Chief Executive Officer, will host a conference call to discuss the results at 10:00 AM ET on Monday, August 10, 2009. Also participating on the call will be Stephanie R. Irish, Acting CFO. To participate in the conference call, dial the appropriate number below shortly before the 10:00 AM start time and ask for the Vanda Pharmaceuticals conference call hosted by Dr. Polymeropoulos. The teleconference dial-in numbers are as follows: Domestic callers 1-800-599-9829 International callers 1-617-847-8703 Participant Passcode 93125446 The conference call will be broadcast simultaneously and archived on the Company's Web site, http://www.vandapharma.com/. Investors should go to the Web site at least 15 minutes early to register, download, and install any necessary audio software. A replay of the call will be available on Monday, August 10, beginning at 1:00 PM ET and will be accessible until Monday, August 17, 2009, at 5:00 PM ET. The replay call-in number is 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers. The access number is 78449791. ABOUT VANDA PHARMACEUTICALS INC.: Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com/. DATASOURCE: Vanda Pharmaceuticals Inc. CONTACT: Stephanie R. Irish, Acting CFO of Vanda Pharmaceuticals Inc., +1-240-599-4500, Web Site: http://www.vandapharma.com/

Copyright